The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models-Reference-Cited by-同舟云学术

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

Published:2019-05-28 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Martínez-Vélez Naiara,Garcia-Moure Marc,Marigil Miguel,González-Huarriz Marisol,Puigdelloses Montse,Gallego Pérez-Larraya Jaime^ORCID,Zalacaín Marta,Marrodán Lucía,Varela-Guruceaga Maider,Laspidea Virginia,Aristu Jose Javier,Ramos Luis Isaac,Tejada-Solís Sonia,Díez-Valle Ricardo,Jones Chris,Mackay Alan,Martínez-Climent Jose A.,García-Barchino Maria Jose,Raabe Eric^ORCID,Monje Michelle^ORCID,Becher Oren J.,Junier Marie Pierre,El-Habr Elias A.,Chneiweiss Herve^ORCID,Aldave Guillermo,Jiang Hong^ORCID,Fueyo Juan,Patiño-García Ana^ORCID,Gomez-Manzano Candelaria,Alonso Marta M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-10043-0.pdf

Reference45 articles.

1. Mackay, A. et al. Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32, 520–537 (2017).

2. Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444–450 (2014).

3. Jones, C. et al. Pediatric high-grade glioma: Biologically and clinically in need of new thinking. Neuro. Oncol. 19, 153–161 (2017).

4. Louis, D. N. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803–820 (2016).

5. Fangusaro, J. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas. in. J. Child. Neurol. 24, 1409–1417 (2009).

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

2. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas;Current Treatment Options in Oncology;2024-06-19

3. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma;Journal of Controlled Release;2024-06

4. Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors;Molecular Therapy: Oncology;2024-06

5. The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles;Molecular Therapy: Oncology;2024-06